These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23413976)

  • 21. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
    Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
    Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5.
    Sinha MD; Turner C; Dalton RN; Rasmussen P; Waller S; Booth CJ; Goldsmith DJ
    Nephrol Dial Transplant; 2012 Dec; 27(12):4361-8. PubMed ID: 22529162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder.
    Hussain I; Tandi R; Singh G; Kaur G; Abhishek ; Dodda S; Patel D; Natarajan B; Maram T; Kedia A; Vempati R; Sahu S; Choubey U
    Cureus; 2023 Jan; 15(1):e33879. PubMed ID: 36812096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK; Essam RM; Morgan MF; Mahmoud RA
    Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
    Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23 and renal function among young and healthy individuals.
    Bernasconi R; Aeschbacher S; Blum S; Mongiat M; Girod M; Todd J; Estis J; Nolan N; Renz H; Risch L; Conen D; Risch M
    Clin Chem Lab Med; 2018 Aug; 56(9):1483-1489. PubMed ID: 29708879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activin A: a marker of mineral bone disorder in children with chronic kidney disease?
    Shankar R; Saha A; Dhull RS; Shroff R; Nangia A; Sharma S
    Pediatr Nephrol; 2024 Sep; 39(9):2773-2777. PubMed ID: 38744714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
    Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.